Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 338.75 | 9.54 | (32.88)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-26 | 392.42 | 49.22 | 45.00¢ | 24.7 | n/a | n/a | n/a | 0.0% |
| 31-Dec-27 | 451.35 | 82.66 | 65.41¢ | 17.0 | 0.4 | +45% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| Dynavax, Merck team up on hepatitis B vaccine | 02-Nov-2007 | BayArea.com |
| Merck Buys License to Sell New Vaccine for Hepat... | 01-Nov-2007 | New York Times |
| Business Digest | 20-Jan-2006 | BayArea.com |
| Currency | US Dollars |
| Share Price | $ 15.40 |
| Change Today | $ 4.27 |
| % Change | 38.32 % |
| 52 Week High | $15.49 |
| 52 Week Low | $9.36 |
| Volume | 30,739,324 |
| Shares Issued | 65.06m |
| Market Cap | $1,001.66m |
| RiskGrade | 699 |
| Strong Buy | 1 |
| Buy | 2 |
| Neutral | 0 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 4 |

| Time | Volume / Share Price |
| 12:59 | 188 @ $15.40 |
| 12:59 | 100 @ $15.39 |
| 12:59 | 144 @ $15.40 |
| 12:59 | 2,000 @ $15.39 |
| 12:59 | 100 @ $15.39 |
You are here: research